Cargando…
E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy
The predictive value of thymidylate synthase (TS) expression alone for 5FU-based treatment of colorectal cancer (CRC) has not been clinically confirmed. Little is known on the association of expression of E2F1, which controls the transcription of genes encoding proteins engaged in DNA synthesis incl...
Autores principales: | Sulzyc-Bielicka, Violetta, Domagala, Pawel, Bielicki, Dariusz, Safranow, Krzysztof, Rogowski, Wojciech, Domagala, Wenancjusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887526/ https://www.ncbi.nlm.nih.gov/pubmed/26831819 http://dx.doi.org/10.1007/s12253-016-0043-z |
Ejemplares similares
-
Expression of p21(WAF1) in Astler–Coller stage B2 colorectal cancer is associated with survival benefit from 5FU-based adjuvant chemotherapy
por: Sulzyc-Bielicka, Violetta, et al.
Publicado: (2011) -
Thymidylate synthase expression and p21(WAF1)/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy
por: Sulzyc-Bielicka, Violetta, et al.
Publicado: (2013) -
Colorectal cancer and Cryptosporidium spp. infection
por: Sulżyc-Bielicka, Violetta, et al.
Publicado: (2018) -
Colorectal cancer and Blastocystis sp. infection
por: Sulżyc-Bielicka, Violetta, et al.
Publicado: (2021) -
Optimal duration of a first-line palliative chemotherapy in disseminated colorectal cancer – a review of the literature from a developing country perspective
por: Rogowski, Wojciech, et al.
Publicado: (2016)